Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

Tesla (TSLA) will release its Q2 2025 financial results on Wednesday, July 31, after the market closes. As usual, ...

Shares of Medpace soared after the company's second-quarter earnings and revenue surpassed expectations. The stock was up 53% to $472.63 in Tuesday's session and is now up 42% on the year.

Tesla is scheduled to report its second-quarter results after the market closes on Wednesday, with investors expecting the electric vehicle maker's stock could make a sizable move.

KeyCorp’s KEY second-quarter 2025 earnings per share from continuing operations of 35 cents surpassed the Zacks Consensus ...

West Pharmaceutical Services WST is scheduled to release second-quarter 2025 results on July 24, before the opening bell. In ...

General Motors' second-quarter core profit fell 32% to $3 billion, as the automaker continued to confront challenging tariff ...

The largest US carmaker anticipates worsening tariff impacts in the third quarter, with trade headwinds potentially costing ...

General Motors is set to report its second-quarter earnings before the bell Tuesday. Wall Street analysts expect adjusted ...

General Motors' second-quarter core profit fell 32% to $3 billion on Tuesday, as the automaker continued to confront ...

Key Points - GAAP earnings per share and revenue for Q2 2025 missed analyst estimates. Net interest income and net interest margin (GAAP) improved significantly, boosted by investment portfolio ...

GM announced its plans to end production of combustion engine vehicles by 2035, as part of its strategy to achieve carbon ...